ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Deciphering essential druggable genes reveals potential immune-inflammatory axis in hepatocellular carcinoma

Wang, Xiaoren; Cui, Xudong; Wang, Wencan; Sun, Jia; Wang, Yan; Han, Wanru; Xie, Xiaotong; Zhu, Zhu; Zhang, Xijun; Yu, Lei*; Liu, Dabin*哈尔滨医科大学
Computers in Biology and Medicine2023-12DOI: 10.1016/j.compbiomed.2023.107625
9阅读
引用收藏
分享

摘要

Background: Hepatocellular carcinoma (HCC) is a malignant tumor with a high mortality rate and poor prognosis in patients. Its pathogenesis is a complex process of multi-factors and multi-steps. However, the etiology and exact molecular mechanism are not completely clear.Methods: Here, we constructed a specific-expressed network based on RNA sequencing data. Gene and miRNA expression profiles and clinical evidence were integrated to detect hepatocellular carcinoma survival modules. Finally, we attempted to identify potential key biomarkers and drug targets by integrating drug sensitivity analysis and immune infiltration analysis.Results: A total of 42 prognostic modules for hepatocellular carcinoma were detected. The prognostic modules were significantly enriched with known cancer-related molecules and 12.93 % molecules of prognostic modules had been found were the targets of small molecule drug. In addition, we found that 38 of 42 (90.48 %) essential genes were associated with the proportions of at least one of the 7 immune cell types.Conclusion: We integrated clinical prognosis information, RNA sequencing data, and drug activity data to explore risk modules of hepatocellular carcinoma. Through drug sensitivity analysis and immune infiltration analysis, we assessed the value of hub genes in the modules as potential biomarkers and drug targets for hepatocellular carcinoma. The protocol provides new insight into parsing the molecular mechanism and theoretical basis of hepatocellular carcinoma.

学科与关键词

关键词
Hepatocellular carcinomaSurvival -related modulesBiomarkersDrug targetsmiRNAImmune infiltration
相关
加载中…
  • Analysis of multiple databases identifies crucial genes correlated with prognosis of hepatocellular carcinoma
    Lin, Zhifeng; Huang, Xuqiong; Ji, Xiaohui; Tian, Nana; Gan, Yu; Ke, Li*Scientific Reports, 2022, 12(1): 9002.被引 1
  • Construction of HBV gene-related prognostic and diagnostic models for hepatocellular carcinoma
    Ma, Keqiang; Wu, Hongsheng*; Ji, Lei*Frontiers in Genetics, 2023, 13: 1065644.
  • The Association between Immune Subgroups and Gene Modules for the Clinical, Cellular, and Molecular Characteristic of Hepatocellular Carcinoma
    Chen, Wenbiao; Zhu, Peng; Xu, Huixuan; Hou, Xianliang; Guo, Changchun*Journal of Oncology, 2022, 2022: 7253876.
查看全部 →

发表信息

论文状态
公开发表
期刊
Computers in Biology and Medicine
发表日期
2023-12
卷期
第 167 卷
页码
107625
DOI
10.1016/j.compbiomed.2023.107625
语言
ENGLISH
成果收录
SCIE

作者

  • W

    Wang, Xiaoren (第一作者)

    2 · harbin med univ

  • C

    Cui, Xudong

    harbin med univ

查看全部 11 位作者收起作者
  • W

    Wang, Wencan

  • S

    Sun, Jia

    harbin med univ

  • W

    Wang, Yan

    harbin med univ

  • H

    Han, Wanru

    harbin med univ

  • X

    Xie, Xiaotong

    harbin med univ

  • Z

    Zhu, Zhu

    harbin med univ

  • Z

    Zhang, Xijun

    harbin med univ

  • Y

    Yu, Lei (通讯)

    harbin med univ

  • L

    Liu, Dabin (通讯)

    harbin med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417